User menu

A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of V gamma 9V delta 2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data.

Bibliographic reference Laurent, Guy ; Van Den Neste, Eric ; Rossi, Jean Francois ; Audibert, Fabien ; Ghesquieres, Herve ; et. al. A Phase I/II Study of IPH1101 (BrHPP), Specific Agonist of V gamma 9V delta 2 T Lymphocytes, in Combination with Rituximab Re-Treatment in Patients with Follicular Lymphoma. Interim Phase I Data..50th Annual Meeting of the American- Society-of-Hematology (San Francisco (Ca), Dec 06-09, 2008). In: Blood, Vol. 112, no. 11, p. 369-369 (2008)
Permanent URL http://hdl.handle.net/2078.1/59027